AMLX Annual Working Capital
$382.62 M
+$47.10 M+14.04%
31 December 2023
Summary:
As of January 23, 2025, AMLX annual working capital is $382.62 million, with the most recent change of +$47.10 million (+14.04%) on December 31, 2023. During the last 3 years, it has risen by +$376.31 million (+5960.89%). AMLX annual working capital is now at all-time high.AMLX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMLX Quarterly Working Capital
$191.35 M
-$65.29 M-25.44%
30 September 2024
Summary:
As of January 23, 2025, AMLX quarterly working capital is $191.35 million, with the most recent change of -$65.29 million (-25.44%) on September 30, 2024. Over the past year, it has dropped by -$197.15 million (-50.75%). AMLX quarterly working capital is now -50.75% below its all-time high of $388.49 million, reached on September 30, 2023.AMLX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMLX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +14.0% | -50.8% |
| 3 y3 years | +5960.9% | -50.8% |
| 5 y5 years | +10000.0% | -50.8% |
AMLX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +337.0% | -50.8% | +118.5% |
| 5 y | 5-year | at high | >+9999.0% | -50.8% | +2931.0% |
| alltime | all time | at high | >+9999.0% | -50.8% | +2931.0% |
Amylyx Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $191.35 M(-25.4%) |
| June 2024 | - | $256.64 M(-19.5%) |
| Mar 2024 | - | $318.89 M(-16.7%) |
| Dec 2023 | $382.62 M(+14.0%) | $382.62 M(-1.5%) |
| Sept 2023 | - | $388.49 M(+6.9%) |
| June 2023 | - | $363.31 M(+7.7%) |
| Mar 2023 | - | $337.44 M(+0.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $335.52 M(+283.2%) | $335.52 M(+140.4%) |
| Sept 2022 | - | $139.55 M(-26.2%) |
| June 2022 | - | $188.97 M(-20.5%) |
| Mar 2022 | - | $237.78 M(+171.6%) |
| Dec 2021 | $87.56 M(+1286.9%) | $87.56 M(-23.7%) |
| Sept 2021 | - | $114.80 M(+1718.4%) |
| Dec 2020 | $6.31 M(-575.7%) | $6.31 M |
| Dec 2019 | -$1.33 M | - |
FAQ
- What is Amylyx Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals annual working capital year-on-year change?
- What is Amylyx Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals quarterly working capital year-on-year change?
What is Amylyx Pharmaceuticals annual working capital?
The current annual working capital of AMLX is $382.62 M
What is the all time high annual working capital for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high annual working capital is $382.62 M
What is Amylyx Pharmaceuticals annual working capital year-on-year change?
Over the past year, AMLX annual working capital has changed by +$47.10 M (+14.04%)
What is Amylyx Pharmaceuticals quarterly working capital?
The current quarterly working capital of AMLX is $191.35 M
What is the all time high quarterly working capital for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high quarterly working capital is $388.49 M
What is Amylyx Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, AMLX quarterly working capital has changed by -$197.15 M (-50.75%)